VivioMD
VivioMD identifies an independent clinical group and licensed pharmacy partners. A June 2026 FDA warning about manufacturer-like product labeling remains relevant when assessing its disclosures and compounded-treatment offers.
Review by Molly Ward, goal-guide writer · Updated October 2026
The short version
Read the warning alongside the current disclosures before considering treatment. Obtain the actual prescriber, dispensing pharmacy and complete recurring price; updated website wording alone does not confirm FDA resolution.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
FDA warning letter on record: Letter 728295 · June 2026
VivioMD Group LLC operates a non-clinical platform for weight care delivered online. Its current homepage describes assessment, a live provider consultation, medication delivery and ongoing support. Clinical services are provided by OpenLoop Healthcare Partners P.C., and affiliated professional entities. The platform is separate from the medical group and pharmacies. Eligibility depends on clinical judgment, and a prescription is not guaranteed.
What VivioMD prescribes, by goal
Weight
- SemaglutideFDA-approved
Listed by the seller; no price we hold.
- TirzepatideFDA-approved
Listed by the seller; no price we hold.
The service markets GLP-1 weight treatment and describes compounded-product limitations. A generic category or product image should not be used to identify a specific formulation. Approved branded medicines and compounded preparations have different regulatory status. The clinician should explain why the selected treatment is appropriate and how its risks are monitored.
Who prescribes
A licensed clinician
The terms name a clinical network through OpenLoop Healthcare Partners P.C., rather than identifying an assigned individual clinician. Pharmacy partners listed are RedRock Pharmacy, Health Warehouse and Triad Rx. Confirm which one will dispense the actual prescription. Current footer wording says VivioMD is neither a pharmacy nor a medication manufacturer and that product imagery is illustrative. Those statements help distinguish the platform’s role from clinical and pharmacy responsibility.
The public pathway begins with a health assessment, then a telehealth consultation before any prescription. A live provider consult is described as included with every plan. Continuing care includes regular check-ins and dose adjustments. Unlimited support access does not establish an immediate physician response or a fixed clinical appointment schedule. The assigned provider should explain the preparation, monitoring and follow-up plan.
Are labs required?
Confirm required testing and cost
A universal required baseline panel, repeat-testing schedule and lab charge were not established. The terms permit charges involving providers, pharmacies and laboratories, so ask which testing is necessary and included.
Ready to start with VivioMD?
Prices and plans are set on the seller's own site.
What it claims, and what it cites
FDA’s June 8, 2026 warning to VivioMD Group LLC concerns images whose labels suggested VivioMD manufactured compounded semaglutide and tirzepatide. The current footer says it does not manufacture medication. No FDA closeout was confirmed; changed wording is not proof of regulatory resolution. The warning concerns labeling representations, not a documented result for a particular patient.
How it bills
No complete current medication-and-dose renewal price was established from the rendered homepage and terms. The page carries a $100 summer promotion banner without a complete continuing bill. Do not treat a seasonal saving or a cached older listing as a current standard rate. Subscriptions automatically renew unless canceled. The refund page requires 72 hours’ notice before the next bill and allows account or email cancellation. Monthly cycles are generally nonrefundable after cancellation, while narrow early unused-service and medical-disqualification exceptions apply. Discount commitments may also be recalculated at full rates if ended early.
For and against
- For: Independent clinical group named
- For: Pharmacy partners listed in terms
- For: Live consultation described
- For: Cancellation channels publicly stated
- Against: Direct FDA warning requires attention
- Against: Current full renewal price not established
- Against: Required testing scope unclear
- Against: Refund and discount conditions restrict flexibility
The evidence behind what it sells
Right for
Someone willing to examine the regulatory record and obtain a precise clinical and financial agreement before making a decision.
Look elsewhere if
A patient seeking a fully specified public price or treating a revised footer as confirmation that FDA concerns are resolved.
Other sellers for weight
Joi + Blokes
Also prescribes Semaglutide, Tirzepatide.
EdgeRx
Also prescribes Semaglutide, Tirzepatide.
YourEra
Also prescribes Semaglutide, Tirzepatide.
VivioMD
Frequently asked questions
- Did FDA issue the warning to the medical group?
- The cited letter is addressed to VivioMD Group LLC dba VivioMD, the platform company.
- Does the current disclaimer prove the issue is closed?
- No. Current wording and an FDA closeout are different things; a closeout was not confirmed.
- Who makes the prescribing decision?
- The independent licensed clinician working through the named medical group, rather than the platform itself.
Sources
- Current care pathway and footer
- Company, clinical group and pharmacies
- Cancellation and refund policy
- Telehealth consent
- FDA warning to the platform company
See what VivioMD prescribes today
VivioMD sets its own prices, plans and the states it serves. Check them before you start.